Telix Pharmaceuticals earnings were $31.4M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest TLX earnings report on Dec 31, 2024 announced Q4 2024 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, TLX reported annual earnings of $31.0M, with 774.7% growth. The next TLX earnings date is Aug 20, 2025.
Telix Pharmaceuticals Earnings Reports & History FAQ
What were Telix Pharmaceuticals's earnings last quarter?
Telix Pharmaceuticals (NASDAQ: TLX) reported Q4 2024 earnings per share (EPS) of N/A, up N/A year over year. Total TLX earnings for the quarter were N/A. In the same quarter last year, Telix Pharmaceuticals's earnings per share (EPS) was N/A.
The next TLX earnings call is Invalid Date. Add TLX to your watchlist to be reminded of Telix Pharmaceuticals's next earnings date.
What was TLX's earnings growth in the past year?
As of Telix Pharmaceuticals's earnings date in Q3 2025, Telix Pharmaceuticals's earnings has grown year over year. TLX earnings in the past year totalled $31.40 million.
Is Telix Pharmaceuticals profitable or losing money?
As of the last Telix Pharmaceuticals earnings report, Telix Pharmaceuticals is currently profitable. Telix Pharmaceuticals's net profit (also called net income) for the twelve months ending Dec 31, 2024 was $31.01 million, a 774.65% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.